Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2017, BioHebe LLC is a venture capital firm based in New York City, NY. The firm specializes in preclinical business development and company formation for therapies aimed at reversing degenerative and chronic diseases. It collaborates with university laboratories, academic institutes, hospitals, and early-stage biotech companies.
BioHebe invests in therapies involving gene and RNA vectors, biologics, compounds, and stem cells. The firm targets the commercialization of preclinical therapies for degenerative diseases such as glaucoma, idiopathic pulmonary fibrosis, and end-stage liver disease. Additionally, it focuses on inherited diseases like Usher Syndrome and oncology diagnostics.
Email info@biohebe.com with your deck to pitch BioHebe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.